This year marks the 50th anniversary of a nearly forgotten hypothesis on aging by Leo Szilard, best known for his pioneering work in nuclear physics, his participation in the Manhattan Project during World War II, his opposition to the nuclear arms race in the postwar era, and his pioneering ideas in biology. Given a specific set of assumptions, Szilard hypothesized that the major reason for the phenomenon of aging was aging hits, e.g., by ionizing radiation, to the gene-bearing chromosomes and presented a mathematical target-hit model enabling the calculation of the average and maximum life span of a species, as well as the influence of increased exposure to DNA-damaging factors on life expectancy. While many new findings have cast doubt on the specific features of the model, this was the first serious effort to posit accumulated genetic damage as a cause of senescence. Here, we review Szilard's assumptions in the light of current knowledge on aging and reassess his mathematical model in an attempt to reach a conclusion on the relevance of Szilard's aging hypothesis today.
L EO Szilard (born in Budapest, Hungary, 1898; died in La Jolla, California, 1964) was one of the leading contributors to the development of nuclear energy and the first atomic bomb. He understood the concept of a nuclear chain reaction in 1933 and filed a patent for his idea the following year (Lanouette 1992) . In 1942, with Enrico Fermi, he set up the first nuclear chain reaction. Realizing the power of what he had helped unleash, he became among the earliest and most active campaigners for nuclear arms control. In spite of intense lobbying, he failed to prevent the bombing of Hiroshima, which was a catastrophic event in his life that eventually made him leave nuclear physics (Lanouette 1992) . In the postwar years, Szilard spent a major portion of his time working to place the control of atomic energy out of the hands of the military and within a civilian department at a global level. He joined the forces of a large number of fellow scientists and formed the Federation of Atomic Scientists, later Federation of American Scientists, which is still active (http:/ /www.fas.org/main/home.jsp). He also made efforts to encourage mutual disarmament and the reduction of tensions between the United States and the Soviet Union. To this end, he was active in the formation of the Pugwash Conferences on Science and World Affairs, together with Albert Einstein, Bertrand Russell, and others, a series of conferences concerned with reducing the danger of armed conflict and seeking cooperative solutions for global problems (http://www. pugwash.org/). In 1962, he helped found the Council for a Livable World, a Washington, D.C.-based lobby organization for nuclear arms control, still active with the goal of providing the U.S. Congress with accurate technical and scientific information to facilitate bal-1 anced decisions about weapons of mass destruction (http://www.clw.org/). Leo Szilard lived a nomadic life and usually had no permanent job or address (Maas and Crow 2004) . However, he had an enormous capacity to grasp novel fields and erect hypotheses for others to test experimentally and was often acknowledged in scientific communications from research groups around the world (Klein 1990; Lanouette 1992) . After World War II, he left nuclear physics for good and turned himself to molecular biology, a field that had developed rapidly in the United States under the lead of Salvador Luria, Max Delbrück, and others (Klein 1990 ). In 1946, he accepted an appointment as professor of biophysics at the University of Chicago. One of his first accomplishments was the development of the Chemostat, an instrument that allows for the maintenance of bacterial populations in growth phase over an indefinite period of time by regulating dissolved oxygen, nutrient concentrations, and pH (Novick and Szilard 1950) . Experiments in the Chemostat revealed, among other things, that the induction of the lac operon was an all-or-none phenomenon (Novick and Weiner 1957) , a result fundamental to the interpretation of the data by Monod and colleagues, defining the concept of negative control of gene expression by repressors (Pardee et al. 1958) . In his Nobel lecture of 1965 (http:/ /nobelprize.org/nobel_ prizes/medicine/laureates/1965/monod-lecture.pdf), Monod acknowledged a significant part of his Nobel Prize to discussions with Szilard, himself never a Nobel laureate. Later in life, Szilard became interested in the biology of aging (Szilard 1959 ) and higher brain functions (Szilard 1964) .
Fifty years ago, Szilard published an article describing a mathematical target-hit model for the aging process (Szilard 1959 ). Szilard's model enables the calculation of the average and maximum life span of a species, as well as the influence of increased exposure to DNAdamaging factors on the aging process. Here, we reassess this largely forgotten article, scrutinize the basic assumptions and calculations being made, describe how the model influenced the thinking about accumulated genetic damage as a cause of aging, and update the model on some of its most outdated assumptions.
SZILARD'S MODEL
Szilard's aging model is based on a number of assumptions, enabling a mathematical description of the aging process. The elementary step in the process is the ''aging hit'' of a chromosome, which renders all genes carried by that chromosome inactive. These aging hits are random events that have a constant probability of occurring per unit time throughout life for a chromosome. A chromosome may also carry an inherited fault, making all its genes inactive from birth. A cell will cease functioning when either both chromosomes in a chromosome pair have suffered aging hits or one of the chromosomes carries an inherited fault and the other one suffers an aging hit (the possibility that both chromosomes in a pair carry inherited faults is neglected). For the female, using a single-hit, multitarget (n ¼ 2) model for chromosome pairs without inherited faults and a single-hit, single-target model for chromosome pairs with an inherited fault, Szilard describes the surviving fraction, f, of somatic cells as
where m is the number of chromosome pairs, r is the number of inherited faults, and j is the average number of aging hits that have been suffered by a somatic cell at a given age:
In Equation 2, t is the ''basic time interval of the aging process,'' i.e., the average time interval between two subsequent aging hits in a somatic cell. It is assumed that t is a characteristic for the species and does not vary appreciably from individual to individual.
Szilard continues to assume that an individual will die within the year in which the surviving fraction has reached a certain critical value, f *. The maximum life span of a species is therefore given by the age at which an individual without inherited faults reaches a surviving fraction of f *. To include a variation in the model, a genetic scattering (stemming from an individual variation in the number of inherited faults) and a nongenetic scattering (estimated from the mean age difference at death between identical twins) are included. Szilard begins by using a Poisson distribution to describe the fluctuation in the number of inherited faults, but to simplify the mathematics he motivates the use of a Gaussian distribution. Using also a Gaussian distribution to describe the nongenetic scattering, comparing the result with the actually observed distribution of the ages of death of the U.S. population in the mid-20th century, and assuming that the critical surviving fraction of somatic cells (f *) is 1 6 , Szilard ends up with an average value of r ¼ 2.5 and a value of t ¼ 6 years for humankind. Thus, using m ¼ 23, all parameters in Equation 1 are known. Szilard then continues to use this result to discuss various subjects such as the ''physiological age,'' the effect of changing the load of inherited faults, and the life-shortening effect of ionizing radiation.
SZILARD'S ASSUMPTIONS
Szilard used the best estimates and assumptions from knowledge accumulated until 1958 to build his model of aging. Some of these assumptions are surprisingly close to present views, while others suffer from the fact that little of the biology of the DNA and protein machinery of the cell was known at that time.
In the following paragraphs, we review Szilard's assumptions and describe some of the criticism his model elicited.
Assumption 1-aging is the accumulation of damaged chromosomes or genes: The focus of Szilard's aging model on damage to chromosomes or genes as a major cause of aging was well in line with experimental data showing that late irradiation damage in animals, e.g., soft tissue atrophy, resembled premature aging (Henshaw et al. 1947) . Since radiation was known to induce mutations, it was proposed that aging could be the result of life-long, low-grade exposure to background radiation and other agents that could damage DNA. As reviewed by Vijg, this view became the foundation of a number of somatic mutation theories of aging, the first of which was Szilard's model (Vijg 2000 ).
Szilard's article immediately elicited criticism. In a letter to Nature, John Maynard Smith showed inconsistencies between predictions based on Szilard's model and observations on the life span of inbred compared with genetically variable wild populations of Drosophila (Maynard Smith 1959) . He later backed away from part of that criticism when considering that, in contrast to mammals, there is almost no cell division in adult insects, making them less suitable to study the role of somatic mutations in aging (Holliday 2000) . The main criticism, however, was directed against the very unlikely assumption that one aging hit would destroy the function of an entire chromosome (Maynard Smith 1959 ). An alternative to the inclusion of chromosome pairs (m) would be to incorporate information on the number of essential genes in a revised model; see revision of the model and simulations below and calculations made in earlier studies (Holliday and Kirkwood 1981; Kirkwood and Proctor 2003) . Szilard actually discusses this possibility but does not follow up on the issue in his calculations. He states that it can be estimated that humankind has $15,000 genes, 3000 of which are important for the functioning of the somatic cells of the adults. Now, this is a very accurate prediction for being made in 1958, 5 years after the unveiling of the structural basis for the genetic code (Watson and Crick 1953) and long before the sequencing of any genome. The best guess today is 20,000-25,000 genes, while we still have no clear idea how many active genes are needed for a somatic cell to be functional. Attempts to calculate the number of essential genes, defined as genes absolutely required for survival, in mice reach numbers in the range of 5000-10,000 (Hentges et al. 2007) , not far from Szilard's estimate.
Is it really correct to emphasize DNA damage as the key causal event in aging? Major arguments in support of a causal relation between DNA damage and aging are the role of DNA as the primary informational biomolecule (Vijg 2000) and the fact that all other macromolecules that are subject to age-related damage (mostly proteins and lipids) are renewable, whereas any acquired error in DNA may have irreversible consequences (Garinis et al. 2008) . Some of the first experimental evidence for a causal relationship between somatic mutations and aging came from studies on mouse liver cells showing an inverse correlation of induced and spontaneous chromosome aberrations with life expectancy. Results corroborating this view have been seen more recently in experiments on cells from humans (Morley et al. 1982; Turner et al. 1985; Ramsey et al. 1995; Tucker et al. 1999) and also in computed models of aging (Kirkwood and Proctor 2003) . As originally suggested by Burnet (1973) , the somatic mutation theory of aging implies that impaired fidelity of the DNA replication and repair system would result in premature aging, a hypothesis supported by a wealth of recent data showing associations of genetic defects in these systems with accelerated aging in both mice and men (Garinis et al. 2008) .
Assumption 2-a certain species is characterized by a certain aging hit rate: The maximum life span is very species specific at the group level (http://genomics. senescence.info/species/). Thus, it would be reasonable to hypothesize either that different genes determine the aging process in different species or that members of a certain species experience different amounts of aging hits to the DNA. In general, the accumulated data have revealed that similar genes affect the aging process in different species but that they act in networks that get more complex and redundant when moving up the evolutionary ladder (Kuningas et al. 2008) . It is well established that the amount of DNA damage per unit time correlates negatively with life span across species (Adelman et al. 1988) . In addition, the DNA repair capacity correlates with life expectancy in different mammals (Hart and Setlow 1974; Burkle et al. 2005) . Thus, Szilard may have been right in his assumption that the rate of manifest aging hits may determine the maximum life span in different species. Another related possibility, however, is that the life span might differ because the number of DNA-damaging hits needed to induce permanent cell-cycle arrest differs between different species.
Assumption 3-aging hits are random events and do not vary interindividually: While the maximum lifespan of an animal species is largely determined by genetic factors, the process of physiological aging varies widely between individuals (Herndon et al. 2002; Passos et al. 2007 ). This dichotomy points to the key importance of stochastic factors in the aging process (Vijg 2000) . On the basis of theoretical and experimental grounds, the random character of many aging phenotypes has often been ascribed to random and destructive chemical modifications of essential biomolecules, such as DNA, by reactive oxygen species (ROS) (Hekimi and Guarente 2003) . Other possible shared effectors of aging include mitochondrial dysfunction and impaired protein homeostasis that leads to accumulation of aberrant proteins through an imbalance in protein biosynthesis, folding, translocation, assembly/disassembly, and/or clearance (Kirkwood and Kowald 1997; Morimoto 2008) . However, biological aging is more than simply the occurrence of random changes in molecules. As discussed above, it is also balanced by the many repair systems found within cells, e.g., the elaborate DNA repair machinery and the ROS-detoxifying systems of all cells and the liver in particular. These biological processes act in parallel, creating a network of interactions (Kirkwood and Kowald 1997) . This opens the way for interindividual variability, e.g., through genetic polymorphisms, both in how the body prevents aging hits and in how it deals with damaged macromolecules.
Assumption 4-the surviving fraction of functional somatic cells determines the biological age of an individual: Szilard's hypothesis postulates that when the surviving fraction of the somatic cells of an individual approaches a critical value, the probability that that individual may die within 1 year becomes very high. Szilard assumes that young mammalian organisms have a large functional reserve and that the surviving fraction of somatic cells may fall substantially before the critical value of $10-30% is reached. The average number of functional cells needed for the body to survive is not known. However, for specific organs it is known that the majority of cells can die before clinical signs of organ failure appear. For example, .50% of the contractile capacity of the heart may be lost before clinical signs of heart failure appear (Aurigemma et al. 2001) , .50% of hippocampal neurons may be lost without any clinical signs of Alzheimer's disease (West et al. 2004) , mice survive an 80% reduction in renal mass without signs of acute renal failure (Al-Awqati and Preisig 1999), and by the time overt type I diabetes appears, almost all insulinproducing cells have disappeared (Foster 1998) . While it is clear that most organs work also after a significant loss of functional cells, Szilard's model with an average value of the critical surviving fraction for the whole organism is a great oversimplification. Another criticism is the failure to recognize that a frequent consequence of mutations is precancerous cell proliferation rather than cell senescence and death.
REVISION OF THE MODEL AND SIMULATIONS
On the basis of current knowledge that it is inaccurate to expect that a single aging hit could inactivate a whole chromosome and following calculations made by Holliday and Kirkwood (1981) , we have revised Szilard's model by replacing the chromosome with the essential gene as the target of the aging hit. Furthermore, instead of including a nongenetic scattering based on the empirical mean age difference at death between female identical twins, we have in our revised model added a fluctuation to the average time interval between two subsequent aging hits in a somatic cell (the ''basic time interval of the aging process,'' t) as well as to the critical surviving fraction, f *.
The introduction of the essential genes instead of the chromosomes as the target for an aging hit does not alter Equation 1, although m and r now correspond to the number of essential gene pairs and the number of inherited faults on the gene level, respectively. The number of essential gene pairs and the average number of inherited faults were estimated to be 10,000 and 20, respectively (McConkey 2003) . Using Szilard's original assumption of the critical value of the survival fraction, f *, as 1 6 , we performed computer simulations to determine the number of deaths as a function of age for a given population. In this way not being limited by mathematics, we used a Poisson distribution to describe the variation in the number of inherited faults (the genetic scattering), as originally suggested by Szilard. The nongenetic scattering, which Szilard obtained from the mean age difference at death between female identical twins, was as described above included by adding a fluctuation to the average time interval between aging hits (t) and to the critical value of the survival fraction (f *).
In Figure 1 , the result of computer simulations of the revised model is compared with Swedish mortality data for females during the year 2007 (47,175 deaths), normalized to 100,000 deaths. The best fit-by-eye of the revised model to the observed mortality data was obtained using a value of the time between two aging hits (t) of 0.34 year and a relative standard deviation of t and f * of 8.3%. Since t now describes the average time interval between two subsequent aging hits in a somatic cell at the gene level, it cannot be compared with the value at the chromosome level, which was 6.0 years in Szilard's original model. Although there is a similarity between the model and the observed data, there are discrepancies. The distribution of the observed mortality data is heavily skewed, with a large number of observed deaths at lower ages, whereas the revised model predicts a more symmetric distribution, thereby underestimating the number of deaths at lower ages and overestimating the number of deaths at higher ages. The underestimation is larger than the overestimation, resulting also in a broader peak for the model than in the observed mortality data.
We also included simulations of Szilard's original model based on chromosomes as the targets in the model. Since the current mortality data are different from those used by Szilard, an adjustment of some of the parameters in Szilard's original model was necessary to obtain a good fit-by-eye to the mortality data. As described above, Szilard obtained the values for the average time interval between two subsequent aging hits in a somatic cell (t) and the average number of inherited faults (average value of r) by fitting the model to observed mortality data of the U.S. population in the mid-20th century. It is therefore natural that slightly different parameter values are needed to fit the model to mortality data obtained half a century later in Sweden. The best fit to current mortality data was obtained by using a value of 6.35 years for t and an average value of r of 1.4. For such small values of r, we are not motivated to use a Gaussian distribution, as Szilard did, and we therefore used a Poisson distribution for the number of inherited faults. The nongenetic scattering was, however, included in the same way as Szilard's by applying a Gaussian distribution with a standard deviation of 3.0 years to the results. It actually turns out (Figure 1 ) that Szilard's original model better fits the observed mortality data than the revised model. This is mainly because the Poisson distribution for an average of 1.4 events, the average number of inherited faults in Szilard's original model determined by fitting the model to observed mortality data, is much more skewed than for an average of 20 events, the average number of inherited faults in the revised model determined from empirical data (McConkey 2003) .
WHAT IS NOT IN THE MODEL?
Two factors, not known at the time when Szilard presented his theory, but intimately linked to cellular senescence and the aging process, are the enzyme telomerase (Greider and Blackburn 1985) and the transcription factor p53 (Rodier et al. 2007) . Cellular senescence was first identified as a process that limits the ability of normal human cells to proliferate in culture to ,70 generations (Hayflick 1965) . It is now established that this limit is caused by at least two interlinked mechanisms: (i) the erosion of telomeres, which are regions at the ends of chromosomes that stabilize DNA, and (ii) stress-induced expression of the p16 tumor suppressor (Campisi 2005a) .
Telomerase adds specific DNA sequence repeats (''TTAGGG'' in all vertebrates) to the 39 end of DNA strands in the telomere regions at the ends of eukaryotic chromosomes. Without telomerase activity, the human chromosomes become shorter during each replication. Eventually, the shortened telomeres loose their ability to hide the chromosome ends from the DNA doublestrand break recognition system, resulting in a sustained DNA damage signal that stops the cell from continuous growth (Palm and De Lange 2008) . In contrast to somatic cells, germ-line cells, some cells of the immune system, and most cancer cells express telomerase activity at a sufficient level to sustain continuous replication of the chromosome ends without loss of genetic material. When telomere lengths are measured in somatic cell cultures, a correlation is observed between telomere length and the number of cell divisions preceding senescence and death (Allsopp et al. 1992) . However, there is now a consensus that telomere length correlates to but does not cause aging in most individuals, with immunosenescence being the most tangible correlate (Effros 2007 ). Exceptions may be a variety of rare premature aging syndromes, such as dyskeratosis congenita (Kirwan and Dokal 2008) and idiopathic pulmonary fibrosis (Blasco 2005) , and some cases of liver cirrhosis (Wiemann et al. 2002) and myelodysplastic syndromes (Ohyashiki et al. 1994) , where mutations in telomere maintenance genes have been identified.
Many other stimuli may induce a senescence response. These include nontelomeric DNA damage, particularly double-strand breaks that activate the p53 pathway, and certain oncogenes that trigger the p16-pRB pathway (Campisi 2005b) . In most human cell systems, only 10-40 double-strand breaks per cell are required for permanent cell-cycle arrest. In his model, Szilard emphasizes ionizing radiation as a potent aging factor. Indeed, ionizing radiation is the most powerful inducer of double-strand breaks and it is well known that radiation therapy causes accelerated aging in exposed tissues (Peters 1996) . However, ionizing radiation does not reduce the fraction of surviving cells by destruction of essential genes as postulated by Szilard. Instead, as stated above, the downstream effect that may be common to all aging phenomena seems to be p53-induced terminal growth arrest and apoptosis. The central role of p53 in this process is corroborated by a number of genetic observations. Transgenic mice expressing overactive forms of p53 get less cancer but age faster than their wild-type controls (Tyner et al. 2002; Maier et al. 2004; Dumble et al. 2007) . While p53 knockout mice develop cancer at such a rate that it is impossible to examine any effects on aging phenotypes, the few p53À/1 that do not get cancer age slower compared with p53 wild-type mice (Donehower et al. 1992) . In addition, humans homozygous for a p53 polymorphism that leads to a mild impairment of p53 function live longer but die 2.5-fold more often from cancer (van Heemst et al. 2005) , suggesting that p53 protects against cancer but at a cost of longevity. Unfortunately, the model suggested by Szilard does not allow for analysis of these types of relatively complicated aging events. To summarize, the model may be considered out of date for the following reasons: (i) the assumption of chromosome inactivation is invalid, (ii) the statistical assumption of a Gaussian distribution is flawed, (iii) the critical surviving fraction of cells is organ specific and cannot be approximated to the whole organism, (iv) the role of cell proliferation in replacing dead or senescent cells is ignored, and (v) there is no recognition in the original model that a frequent consequence of DNA damage is precancerous cell proliferation rather than cell senescence and apoptosis. Nevertheless, Szilard's model was the first serious hypothesis to posit accumulated genetic damage as an important cause of senescence, a view most researchers agree with today (Garinis et al. 2008) , and in spite of being oversimplified and on some aspects wrong, it also predicts population-based death rates in a quite accurate manner. In the literature, Szilard is often described as a visionary man with a remarkable ability to make accurate predictions on grounds not always clear to his fellow scientists. In a sense, his model of the aging process may be another example of this extraordinary gift.
